162 In the index

VIP VIP

A natural hormone-like signal in the body involved in relaxing blood vessels and regulating secretions, studied mainly in the context of a lung-blood-pressure condition and certain hormone-related tumors. Outside these specific medical and research uses, VIP isn't typically given as a standalone treatment, so broader human data are limited.

Also known as Vasoactive intestinal polypeptide, VASOACTIVE INTESTINAL PEPTIDE, 6J2WVD66KR, CCRIS 7231, VIP [MI], VASOACTIVE INTESTINAL PEPTIDE (HUMAN)

Effects Heal Immune

Routes Nasal

Legal status Research chemical

WADA Not listed

Molecular Structure of C₁₄₇H₂₃₇N₄₃O₄₃S

Drag to rotate · scroll to zoom

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula: C147H237N43O43S
Molar mass: 3326.8
CAS: 37221-79-7
PubChem CID: 53314964
IUPAC name: (2S)-4-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid
InChIKey: VBUWHHLIZKOSMS-RIWXPGAOSA-N

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established for general use; primarily a research/diagnostic agent

Reported range Clinical research doses: variable by protocol, typically low-microgram IV infusions

Route Intravenous infusion

Frequency Per research protocol

Duration Not established for chronic use

Vasoactive intestinal peptide; studied mainly in the context of a lung-blood-pressure condition and certain hormone-related tumors rather than sold as a standalone consumer product.

Where this comes from Published clinical research studies

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.